Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

PST-2238: a selective Na+/K+-ATPase inhibitor

July 19, 1996

Potent selective protein farnesyltransferase inhibitor from Pierre Fabre

July 19, 1996

Hybridon's GEM-91 inhibits various steps in HIV-1 replication

July 19, 1996

RWJ-26819: Non-steroidal progestin agonist from R.W. Johnson

July 12, 1996

KGR-1380: A novel glycation inhibitor

July 12, 1996

NEP inhibition research findings

July 12, 1996

WAY-126120: Selective PDE IV inhibitor

July 12, 1996

Muscarinic receptor ligand selected for further study

July 12, 1996

Pharmacia & Upjohn's dopamine D4 receptor ligands

July 12, 1996

Potent, selective mGluR2 agonist from Lilly

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...